Arca Biopharma, Inc.
Records under this name other than patents Arca Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,847,067 | Antibodies to NTB-A Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,536,310 | Antibodies to CLL-1 Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,446,023 | Methods and Compositions Involving (S)-Bucindolol Formerly held In force · High confidence | In force | High confidence | |
| US 9,763,916 | Methods and Compositions Involving (S)-Bucindolol Formerly held In force · High confidence | In force | High confidence | |
| US 8,946,284 | Methods and Compositions Involving (S)-Bucindolol Formerly held In force · High confidence | In force | High confidence | |
| US 10,925,856 | Methods and Compositions Involving Bucindolol for the Treatment of Atrial Fibrillation Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,554,107 | Methods and Compositions Involving Bucindolol for the Treatment of Atrial Fibrillation Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,491,177 | Methods and Compositions Involving Bucindolol for the Treatment of Atrial Fibrillation Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,452,712 | Methods and Compositions Involving (S)-Bucindolol Formerly held Lapsed on the fee record Ended Sep 27, 2026 · High confidence | Lapsed on the fee record | Ended Sep 27, 2026 | High confidence |
| US 8,715,941 | Antibodies to LRP6 Lapsed on the fee record Ended May 6, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 6, 2026 | From the USPTO record |